U.S. House Passes Bill That Would Require Disclosure of Beneficial Owners of U.S. Corporations and Limited Liability Companies

By Saar Warner-Lipton on November 4, 2019 Posted in Corporate

A newly approved Bill could significantly increase disclosure requirements for Israelis invested in or operating business in the U.S. The Corporate Transparency Act of 2019 would require that the identities (including addresses and passport information) of the “beneficial owners” of US LLC’s or corporations be reported. Updated information would need to provided annually. While similar … Continue Reading

2 Recent Cases Impacting False Claims Act Litigation and Investigations Deserve the Attention of Health Care Providers and Private Equity Investors

By Mark L. Mattioli and Jessica Natali on October 28, 2019 Posted in Health Care & FDA

The United States Attorney’s Office for the Southern District of Florida announced on Sept. 19, 2019, that it settled a qui tam False Claims Act case in which a private equity firm was a named defendant. See United States ex rel. Medrano and Lopez v. Diabetic Care Rx LLC, d/b/a Patient Care America, et al., … Continue Reading

Does Section 1782 Apply to Discovery in Private International Commercial Arbitration Proceedings?

By Thomas G. Allen‡, Tomás Leonard, Nicole Y. Silver and Andrew Van Duzer on October 9, 2019 Posted in Commercial Agreements, Israel, Litigation

Life sciences companies should pay attention to an ongoing action in Delaware that could have implications for whether they can obtain (or be subjected to) U.S. discovery in international arbitration under 28 U.S.C. § 1782. Section 1782 is a powerful tool that permits litigants to obtain broad discovery in the United States for use in … Continue Reading